Medtronic Releases Fiscal Year 2017 Integrated Performance Report
November 02 2017 - 2:00PM
YASTEST
Report Highlights
Company's Global Financial, Social, and Environmental
Impact
DUBLIN - November 2, 2017 -
Medtronic plc (NYSE:MDT) announces the release of its fiscal year
2017 Integrated Performance Report. The report highlights the
combined financial, social, and environmental impact of
Medtronic.
The FY2017 Integrated Performance Report details
the company's commitment to addressing business and industry
challenges. Based on the Global Reporting Initiative (GRI) G4
Guidelines, it's organized around the Medtronic sustainability
material issues:
- Access to Care
- Product Quality
- Product Stewardship
- Responsible Supply Management
- Ethics in Sales and Marketing
A tenet of the Medtronic Mission - to maintain
good citizenship as a company - drives a sense of purpose and
responsibility to not only deliver the highest quality products,
therapies, and services to patients, but to also support healthy
communities in the areas in which it operates.
In fiscal year 2017, Medtronic:
-
Invested $2.2 billion in research and
development, representing 7.4 percent of net sales
-
Launched Medtronic Labs, a new initiative
designed to deliver financially sustainable businesses that expand
access and reduce health inequality in emerging markets
-
Invested $139.7 million in capacity building and
training for medical professionals and $22.6 million in patient
education
-
Donated $101.8 million to charitable causes
through corporate cash contributions, giving through the Medtronic
Foundation, product donations, and employee volunteering
-
Invested more than $76 million in employee
training and development programs
-
Reached early achievements of four of its 2020
Environmental Performance Goals, including reductions in energy,
emissions, waste, and water
The report and Global Reporting Initiative (GRI)
Supplement is available for download at
www.medtronic.com/SustainabilityReport.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin,
Ireland, is among the world's largest medical technology, services
and solutions companies - alleviating pain, restoring health and
extending life for millions of people around the world. Medtronic
employs more than 84,000 people worldwide, serving physicians,
hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to
take healthcare Further, Together.
Any forward-looking statements in
this release or the 2017 Integrated Performance Report are subject
to risks and uncertainties such as those described in Medtronic's
periodic reports on file with the Securities and Exchange
Commission. Actual results may differ materially from anticipated
results.
-end-
Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780
Ryan Weispfenning
Investor Relations
+1-763-505-4626
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Medtronic plc via Globenewswire
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024